Parallax Volatility Advisers’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-27,000
| Closed | -$2.59M | – | 1709 |
|
|
2025
Q4 | $2.59M | Buy |
27,000
+1,700
| +7% | +$165K | 0.01% | 878 |
|
|
2025
Q3 | $2.41M | Sell |
25,300
-102,200
| -80% | -$9.39M | ﹤0.01% | 867 |
|
|
2025
Q2 | $11.1M | Buy |
127,500
+55,000
| +76% | +$4.66M | 0.03% | 402 |
|
|
2025
Q1 | $6.51M | Buy |
72,500
+72,300
| +36,150% | +$6.47M | 0.02% | 549 |
|
|
2024
Q4 | $16K | Sell |
200
-25,000
| -99% | -$2.16M | ﹤0.01% | 1848 |
|
|
2024
Q3 | $2.27M | Sell |
25,200
-4,800
| -16% | -$404K | ﹤0.01% | 1084 |
|
|
2024
Q2 | $2.36M | Sell |
30,000
-100
| -0.3% | -$8.2K | 0.01% | 987 |
|
|
2024
Q1 | $2.62M | Sell |
30,100
-266,700
| -90% | -$22.8M | 0.01% | 941 |
|
|
2023
Q4 | $24.5M | Buy |
296,800
+263,400
| +789% | +$20.1M | 0.05% | 335 |
|
|
2023
Q3 | $2.62M | Sell |
33,400
-72,100
| -68% | -$6.04M | 0.01% | 997 |
|
|
2023
Q2 | $9.29M | Buy |
105,500
+63,200
| +149% | +$5.44M | 0.02% | 561 |
|
|
2023
Q1 | $3.41M | Buy |
42,300
+29,900
| +241% | +$2.44M | 0.01% | 1018 |
|
|
2022
Q4 | $964K | Sell |
12,400
-122,300
| -91% | -$9.91M | ﹤0.01% | 1668 |
|
|
2022
Q3 | $10.9M | Buy |
134,700
+38,700
| +40% | +$3.48M | 0.02% | 740 |
|
|
2022
Q2 | $8.62M | Buy |
96,000
+60,100
| +167% | +$6.09M | 0.01% | 784 |
|
|
2022
Q1 | $3.98M | Sell |
35,900
-43,300
| -55% | -$4.57M | ﹤0.01% | 1078 |
|
|
2021
Q4 | $8.19M | Sell |
79,200
-107,100
| -57% | -$12.4M | 0.01% | 653 |
|
|
2021
Q3 | $23.4M | Sell |
186,300
-69,000
| -27% | -$8.93M | 0.02% | 413 |
|
|
2021
Q2 | $31.7M | Buy |
+255,300
| New | +$32.1M | 0.04% | 277 |
|
|
2021
Q1 | – | Sell |
-520,400
| Closed | -$61M | – | 1880 |
|
|
2020
Q4 | $61M | Sell |
520,400
-621,900
| -54% | -$68.5M | 0.06% | 260 |
|
|
2020
Q3 | $119M | Buy |
1,142,300
+604,900
| +113% | +$60.7M | 0.09% | 199 |
|
|
2020
Q2 | $49.3M | Buy |
537,400
+253,200
| +89% | +$24.3M | 0.06% | 271 |
|
|
2020
Q1 | $25.6M | Buy |
284,200
+86,300
| +44% | +$9.18M | 0.03% | 350 |
|
|
2019
Q4 | $22.5M | Sell |
197,900
-115,100
| -37% | -$12.6M | 0.03% | 391 |
|
|
2019
Q3 | $34M | Sell |
313,000
-25,300
| -7% | -$2.64M | 0.04% | 252 |
|
|
2019
Q2 | $32.9M | Buy |
338,300
+400
| +0.1% | +$36.5K | 0.04% | 243 |
|
|
2019
Q1 | $30.8M | Sell |
337,900
-1,230,700
| -78% | -$110M | 0.04% | 238 |
|
|
2018
Q4 | $143M | Sell |
1,568,600
-123,700
| -7% | -$11.6M | 0.19% | 75 |
|
|
2018
Q3 | $166M | Buy |
1,692,300
+694,200
| +70% | +$64.2M | 0.2% | 46 |
|
|
2018
Q2 | $85.4M | Buy |
998,100
+248,100
| +33% | +$20.7M | 0.12% | 78 |
|
|
2018
Q1 | $60.2M | Buy |
+750,000
| New | +$61.9M | 0.08% | 116 |
|
|
2017
Q1 | – | Sell |
-15,000
| Closed | -$1.07M | – | 4220 |
|
|
2016
Q4 | $1.07M | Sell |
15,000
-60,000
| -80% | -$4.71M | ﹤0.01% | 1196 |
|
|
2016
Q3 | $6.48M | Buy |
75,000
+70,700
| +1,644% | +$6.16M | 0.01% | 586 |
|
|
2016
Q2 | $373K | Buy |
+4,300
| New | +$348K | ﹤0.01% | 1580 |
|
|
2014
Q3 | – | Sell |
-136,600
| Closed | -$8.71M | – | 4365 |
|
|
2014
Q2 | $8.71M | Sell |
136,600
-127,900
| -48% | -$7.77M | 0.04% | 352 |
|
|
2014
Q1 | $16.3M | Buy |
264,500
+14,200
| +6% | +$827K | 0.1% | 178 |
|
|
2013
Q4 | $14.4M | Buy |
250,300
+123,300
| +97% | +$6.99M | 0.07% | 229 |
|
|
2013
Q3 | $6.76M | Sell |
127,000
-6,900
| -5% | -$371K | 0.04% | 317 |
|
|
2013
Q2 | $6.89M | Buy |
+133,900
| New | +$6.62M | 0.03% | 347 |
|
Other funds holding MDT
VCM
VPM
Parallax Volatility Advisers's MDT Position: Q1 2026 in Review
Parallax Volatility Advisers reduced its Medtronic (MDT) stake by 90% in Q1 2026, selling an estimated $1.77M and leaving 1,956 shares worth $160K. The position accounts for ﹤0.01% of the portfolio, ranked #1199.
Parallax Volatility Advisers first reported a position in MDT in Q3 2014 and has held it in 21 quarters since. The position peaked at $33.3M in Q2 2019. 2,231 funds tracked by Wall St. Rank hold MDT as of Q1 2026.
- Parallax Volatility Advisers held 1,956 shares of Medtronic worth $160K as of Q1 2026.
- Parallax Volatility Advisers sold 18,431 Medtronic shares in Q1 2026, an estimated $1.77M.
- Medtronic made up ﹤0.01% of Parallax Volatility Advisers's portfolio in Q1 2026, its #1199 holding.
- Parallax Volatility Advisers first reported a position in Medtronic in Q3 2014 and has held it in 21 quarters since.
- Parallax Volatility Advisers's Medtronic position peaked at $33.3M in Q2 2019.
- 2,231 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.
Based on Parallax Volatility Advisers's 13F filing for Q1 2026, filed 15 May 2026.